These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 4264575)

  • 1. The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator.
    Kaplan AP; Austen KF
    J Exp Med; 1972 Dec; 136(6):1378-93. PubMed ID: 4264575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator.
    Kaplan AP; Goetzl EJ; Austen KF
    J Clin Invest; 1973 Oct; 52(10):2591-5. PubMed ID: 4729052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin.
    Kaplan AP; Austen KF
    J Exp Med; 1971 Apr; 133(4):696-712. PubMed ID: 4251126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen.
    Mandle RJ; Kaplan AP
    Blood; 1979 Oct; 54(4):850-62. PubMed ID: 89876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XII-induced fibrinolysis: studies on the separation of prekallikrein, plasminogen proactivator, and factor XI in human plasma.
    Laake K; Venneröd AM
    Thromb Res; 1974 Feb; 4(2):285-302. PubMed ID: 4208626
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma inhibitors of the components of the fibrinolytic pathway in man.
    Schreiber AD; Kaplan AP; Austen KF
    J Clin Invest; 1973 Jun; 52(6):1394-401. PubMed ID: 4122174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.
    Colman RW; Bagdasarian A; Talamo RC; Scott CF; Seavey M; Guimaraes JA; Pierce JV; Kaplan AP
    J Clin Invest; 1975 Dec; 56(6):1650-62. PubMed ID: 1202089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of Hageman factor (factor XII) of the guinea pig to prekallikrein activator and inhibition of the formed kallikrein by a natural plasma inhibitor.
    Takeuchi Y; Movat HZ
    Eur J Immunol; 1972 Aug; 2(4):345-9. PubMed ID: 4538864
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors.
    Ogston D; Ogston CM; Ratnoff OD; Forbes CD
    J Clin Invest; 1969 Oct; 48(10):1786-801. PubMed ID: 4241814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator.
    Kluft C; Trumpi-Kalshoven MM; Jie AF; Veldhuyzen-Stolk EC
    Thromb Haemost; 1979 Jun; 41(4):756-73. PubMed ID: 483248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proactivator-activator system in human plasma fibrinolysis: studies on the synthetic fibrinolytic system composed of functionally pure fibrinogen, plasminogen and proactivator, separated from human plasma].
    Okamoto U
    Nihon Seirigaku Zasshi; 1972 Mar; 34(3):147-55. PubMed ID: 4262660
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of HF cofactor in the Hageman factor-dependent fibrinolytic mechanism.
    Iatridis PG; Gadarowski JJ; Iatridis SG
    Acta Haematol; 1981; 66(4):257-63. PubMed ID: 6800192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrates of Hageman factor. I. Isolation and characterization of human factor XI (PTA) and inhibition of the activated enzyme by alpha 1-antitrypsin.
    Heck LW; Kaplan AP
    J Exp Med; 1974 Dec; 140(6):1615-30. PubMed ID: 4547783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis.
    Mandle R; Kaplan AP
    J Biol Chem; 1977 Sep; 252(17):6097-104. PubMed ID: 408348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation.
    Schreiber AD; Kaplan AP; Austen KF
    J Clin Invest; 1973 Jun; 52(6):1402-9. PubMed ID: 4703226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of a prealbumin activator of prekallikrein from acetone-activated human plasma.
    Venneröd AM; Laake K
    Thromb Res; 1974 Jan; 4(1):103-18. PubMed ID: 4829662
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrinolysis in normal plasma and blood: evidence for significant mechanisms independent of the plasminogen-plasmin system.
    Moroz LA; Gilmore NJ
    Blood; 1976 Oct; 48(4):531-45. PubMed ID: 134751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of factor XII-dependent plasminogen proactivator in prekallikrein-deficient plasma.
    Bouma BN; Griffin JH
    J Lab Clin Med; 1978 Jan; 91(1):148-55. PubMed ID: 73563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XII-induced fibrinolysis. Diminished proactivator activity and drastic reduction of activator activity in Fletcher factor-deficient plasma gamma globulin.
    Espana F; Aznar J; Estelles A
    J Lab Clin Med; 1982 Nov; 100(5):756-70. PubMed ID: 6182261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin-generation.
    Kaplan AP; Meier HL; Mandle R
    Semin Thromb Hemost; 1976 Jul; 3(1):1-26. PubMed ID: 139682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.